Bio-Rad Laboratories (BIO) Competitors $227.39 -0.59 (-0.26%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, community ranking, dividends, earnings, institutional ownership and analyst recommendations. Which has more risk & volatility, MTD or BIO? Mettler-Toledo International has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500. Does the MarketBeat Community favor MTD or BIO? Bio-Rad Laboratories received 2 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 64.77% of users gave Bio-Rad Laboratories an outperform vote while only 56.26% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformMettler-Toledo InternationalOutperform Votes37356.26% Underperform Votes29043.74% Bio-Rad LaboratoriesOutperform Votes37564.77% Underperform Votes20435.23% Does the media refer more to MTD or BIO? In the previous week, Mettler-Toledo International had 20 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 28 mentions for Mettler-Toledo International and 8 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.53 beat Mettler-Toledo International's score of 1.40 indicating that Bio-Rad Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 22 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Rad Laboratories 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is MTD or BIO more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Bio-Rad Laboratories' net margin of -71.86%. Bio-Rad Laboratories' return on equity of 3.90% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International22.29% -591.54% 26.78% Bio-Rad Laboratories -71.86%3.90%2.76% Do insiders & institutionals believe in MTD or BIO? 95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are held by institutional investors. 0.8% of Mettler-Toledo International shares are held by company insiders. Comparatively, 17.8% of Bio-Rad Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer MTD or BIO? Mettler-Toledo International presently has a consensus price target of $1,302.11, suggesting a potential upside of 15.38%. Bio-Rad Laboratories has a consensus price target of $327.40, suggesting a potential upside of 44.62%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40Bio-Rad Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has preferable earnings and valuation, MTD or BIO? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$3.83B6.12$863.14M$40.1028.14Bio-Rad Laboratories$2.54B2.42-$1.84B-$76.20-2.97 SummaryMettler-Toledo International beats Bio-Rad Laboratories on 11 of the 18 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$6.16B$4.29B$5.32B$19.29BDividend YieldN/A0.57%5.21%3.83%P/E Ratio-3.4826.4026.7734.47Price / Sales2.423.75390.2234.86Price / Cash26.9536.2438.2517.51Price / Book0.971.536.754.67Net Income-$1.84B-$84.30M$3.23B$1.02B7 Day Performance-6.81%1.96%1.55%-2.17%1 Month Performance-7.70%3.12%12.22%7.01%1 Year Performance-22.43%-23.23%16.71%3.59% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.7983 of 5 stars$227.39-0.3%$327.40+44.0%-21.1%$6.19B$2.54B-3.508,200Positive NewsMTDMettler-Toledo International4.4723 of 5 stars$1,175.33+8.7%$1,296.13+10.3%-25.6%$24.43B$3.83B29.0018,000News CoveragePositive NewsAnalyst UpgradeWATWaters3.9654 of 5 stars$366.80+6.6%$390.19+6.4%-1.3%$21.83B$2.98B34.258,200Trending NewsAnalyst UpgradeILMNIllumina4.7996 of 5 stars$81.57+7.7%$130.95+60.5%-26.2%$12.91B$4.37B-10.6211,500Analyst ForecastGap DownTECHBio-Techne4.8435 of 5 stars$53.90+7.9%$73.44+36.3%-43.6%$8.52B$1.21B54.443,000Positive NewsDividend AnnouncementEx-DividendHigh Trading VolumeCRLCharles River Laboratories International4.9077 of 5 stars$143.06+3.1%$176.00+23.0%-39.0%$7.03B$4.02B953.7121,400Positive NewsHigh Trading VolumeBRKRBruker4.9305 of 5 stars$40.26+7.3%$60.10+49.3%-52.3%$6.10B$3.45B52.978,520Dividend AnnouncementAnalyst ForecastHigh Trading VolumePACBPacific Biosciences of California1.6142 of 5 stars$1.10-1.8%$2.50+127.3%-46.4%$330.05M$152.36M-0.67730HBIOHarvard Bioscience3.8209 of 5 stars$0.35+11.8%$4.50+1,178.0%-90.0%$15.57M$94.14M-1.07490Analyst ForecastHigh Trading VolumeTMOThermo Fisher Scientific4.994 of 5 stars$432.16+7.2%$607.43+40.6%-32.6%$163.14B$42.90B26.14130,000Trending NewsDividend AnnouncementAnalyst UpgradeAnalyst RevisionHigh Trading VolumeAAgilent Technologies4.8443 of 5 stars$115.53+8.0%$143.00+23.8%-29.2%$32.94B$6.51B26.5617,900Trending NewsUpcoming EarningsDividend AnnouncementAnalyst Forecast Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
